PRECLINICAL EVALUATION OF THERAPIES OF CRYPTOSPORIDIUM PARVUM NIH GUIDE, Volume 25, Number 10, March 29, 1996 RFP AVAILABLE: NIH-NIAID-DAIDS-97-05 P.T. 34 Keywords: Chemotherapy Infectious Diseases/Agents National Institute of Allergy and Infectious Diseases The NIAID, DAIDS, has a requirement to quantitatively evaluate therapeutic agents for efficacy against Cryptosporidium parvum infection in a standardized, validated immunocompromised mouse model test system. In vivo studies will include evaluation of therapies in combination in the primary mouse model; evaluation of therapies in a validated, standardized animal model for hepatobiliary disease; and evaluation of therapies using alternative strains of Cryptosporidium. Therapeutic agents will be evaluated for efficacy in a standardized, reproducible, and validated in vitro test system using intact organisms. The offeror should have available a primary mouse model of Cryptosporidium infection and an in vitro system (including relevant Cryptosporidium isolates) suitable for the evaluation of therapies with potential for treatment of Cryptosporidium infections in people with AIDS. It is anticipated that one cost reimbursement, level-of-effort type contract will be awarded for a period of five years beginning on or about July 23, 1997. It is estimated that 1,675% total effort will be needed for this acquisition during the five-year period. RFP NIH-NIAID-DAIDS-97-05 will be available electronically on or about April 15, 1996, and may be accessed through either the NIH Gopher or the NIH Home Page by using the following electronic mail addresses and instructions: 1) To access the NIH Gopher: Point your gopher client to GOPHER.NIH.GOV PORT 70. (You should now be in the NIH Gopher.) Select "Grant and Research Information," then select "R&D Request for Proposals" (RFP). 2) NIH Home Page (via the World Wide Web): Access the NIH Home Page by using http://www.nih.gov. Once you are at the NIH Home Page, select "Grants and Contracts," then select "R&D Requests for Proposals (RFP)." Responses to this RFP will be due on August 15, 1996. Any responsible offeror may submit a proposal which will be considered by the Government. This advertisement does not commit the Government to award a contract. INQUIRIES Inquiries regarding this RFP may be directed to: Bruce E. Anderson Contract Management Branch National Institute of Allergy and Infectious Diseases 6003 Executive Boulevard, Room 3C-07 - MSC 7610 Bethesda, MD 20892-7610 Telephone: (301) 496-8371 FAX: (301) 402-0972 Email: ba9i@nih.gov No collect calls will be accepted. .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |